Ro valuation, funding and investors

ro.co ↗LinkedIn ↗

Ro works in telehealth services, based in New York, United States. Founded in 2017, it has about 1,480 employees.

Health Care Services New York Growth Equity

VALUATION · TODAY

$5.67B −2% after Growth

Range $844M – $8.58B · Grade D

TODAY

+12 MO

$10.00B

$20.00B

$30.00B

$40.00B

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

Seed $3.00M

Series A $88.0M

Series B $85.0M

Series C $200M

Series D $500M

Growth $150M

ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then

HEADCOUNT · TODAY1,481 employees

+5%6m growth

+24%1y growth

+53%2y growth

1,000

2,000

Data from Jan 2021

TODAY

Predicted in 1 yr $5.58B −2% vs today

Predicted next raise $693M if a round comes

Winding-down probability 0%

Last round: Growth · $150M · Feb 2022
Valuation at last round: $7.00B
Headcount: 1,481 · up
Grade: D
Founded: 2017

How VCMC values companies →

Ro valuation today

VCMC values Ro at $5.7B today, with a range of $844M to $8.6B and a grade of D. The valuation starts from its last funding round, a growth round in Feb 2022.

Valuation by date (125 rows)

Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.

Ro: valuation by date, as the model would have shown it on each date
Date	Valuation	Range	Predicted in 1 yr	Phase	Headcount	Trend	Grade	Winding-down probability
1 Jan 2017	$6.60M	$2.40M – $18.1M	$9.05M (+37%)	before first round	–	unknown	D	0%
1 Feb 2017	$6.78M	$2.47M – $18.6M	$9.29M (+37%)	before first round	–	unknown	D	0%
1 Mar 2017	$6.94M	$2.53M – $19.1M	$9.52M (+37%)	before first round	–	unknown	D	0%
1 Apr 2017	$7.13M	$2.60M – $19.6M	$9.78M (+37%)	before first round	–	unknown	D	0%
1 May 2017	$7.32M	$2.67M – $20.1M	$10.0M (+37%)	before first round	–	unknown	D	0%
1 Jun 2017	$7.52M	$2.74M – $20.7M	$10.3M (+37%)	before first round	–	unknown	D	0%
1 Jul 2017	$7.72M	$2.81M – $21.2M	$10.6M (+37%)	before first round	–	unknown	D	0%
1 Aug 2017	$7.93M	$2.89M – $21.8M	$10.9M (+37%)	before first round	–	unknown	D	0%
4 Aug 2017	$12.0M	$7.88M – $36.5M	$24.0M (+100%)	after a round	–	unknown	C	0%
1 Sep 2017	$12.7M	$7.88M – $36.5M	$24.0M (+89%)	after a round	–	unknown	C	0%
1 Oct 2017	$13.4M	$7.88M – $36.5M	$24.0M (+79%)	after a round	–	unknown	C	0%
1 Nov 2017	$14.2M	$7.88M – $36.5M	$24.0M (+69%)	after a round	–	unknown	C	0%
1 Dec 2017	$15.1M	$7.88M – $36.5M	$24.0M (+59%)	after a round	–	unknown	C	0%
1 Jan 2018	$16.0M	$7.88M – $36.5M	$24.0M (+50%)	after a round	–	unknown	C	0%
1 Feb 2018	$17.0M	$7.88M – $36.5M	$24.0M (+42%)	after a round	–	unknown	C	0%
1 Mar 2018	$17.9M	$7.88M – $36.5M	$24.0M (+34%)	after a round	–	unknown	C	0%
1 Apr 2018	$19.0M	$7.88M – $36.5M	$24.0M (+27%)	after a round	–	unknown	C	0%
1 May 2018	$20.1M	$7.88M – $36.5M	$24.0M (+20%)	after a round	–	unknown	C	0%
1 Jun 2018	$21.3M	$7.88M – $36.5M	$24.0M (+13%)	after a round	–	unknown	C	0%
1 Jul 2018	$22.5M	$7.88M – $36.5M	$24.0M (+7%)	after a round	–	unknown	C	0%
1 Aug 2018	$23.9M	$7.88M – $36.5M	$24.0M (0%)	after a round	–	unknown	C	0%
1 Sep 2018	$24.0M	$7.52M – $36.5M	$24.0M (0%)	after a round	–	unknown	C	0%
20 Sep 2018	$191M	$135M – $488M	$344M (+80%)	after a round	–	unknown	C	0%
1 Oct 2018	$195M	$135M – $488M	$344M (+77%)	after a round	–	unknown	C	0%
1 Nov 2018	$205M	$135M – $488M	$344M (+68%)	after a round	–	unknown	C	0%
1 Dec 2018	$215M	$135M – $488M	$344M (+60%)	after a round	–	unknown	C	0%
1 Jan 2019	$226M	$135M – $488M	$344M (+52%)	after a round	–	unknown	C	0%
1 Feb 2019	$237M	$135M – $488M	$344M (+45%)	after a round	–	unknown	C	0%
1 Mar 2019	$248M	$135M – $488M	$344M (+38%)	after a round	–	unknown	C	0%
1 Apr 2019	$261M	$135M – $488M	$344M (+32%)	after a round	–	unknown	C	0%
17 Apr 2019	$501M	$435M – $863M	$750M (+50%)	after a round	–	unknown	B	0%
1 May 2019	$508M	$435M – $863M	$750M (+48%)	after a round	–	unknown	B	0%
1 Jun 2019	$526M	$435M – $863M	$750M (+43%)	after a round	–	unknown	B	0%
1 Jul 2019	$544M	$435M – $863M	$750M (+38%)	after a round	–	unknown	B	0%
1 Aug 2019	$563M	$435M – $863M	$750M (+33%)	after a round	–	unknown	B	0%
1 Sep 2019	$583M	$435M – $863M	$750M (+29%)	after a round	–	unknown	B	0%
1 Oct 2019	$603M	$435M – $863M	$750M (+24%)	after a round	–	unknown	B	0%
1 Nov 2019	$624M	$435M – $863M	$750M (+20%)	after a round	–	unknown	B	0%
1 Dec 2019	$645M	$435M – $863M	$750M (+16%)	after a round	–	unknown	B	0%
1 Jan 2020	$667M	$435M – $863M	$750M (+12%)	after a round	–	unknown	B	0%
1 Feb 2020	$691M	$435M – $863M	$750M (+9%)	after a round	–	unknown	B	0%
1 Mar 2020	$713M	$435M – $863M	$750M (+5%)	after a round	–	unknown	B	0%
1 Apr 2020	$738M	$435M – $863M	$750M (+2%)	after a round	–	unknown	B	0%
1 May 2020	$750M	$425M – $863M	$750M (0%)	after a round	–	unknown	B	0%
1 Jun 2020	$750M	$407M – $863M	$750M (0%)	after a round	–	unknown	B	0%
1 Jul 2020	$750M	$390M – $863M	$750M (0%)	after a round	–	unknown	B	0%
28 Jul 2020	$1.5B	$1.3B – $2.2B	$2.0B (+30%)	after a round	–	unknown	A	0%
1 Aug 2020	$1.5B	$1.3B – $2.2B	$2.0B (+30%)	after a round	–	unknown	A	0%
1 Sep 2020	$1.5B	$1.3B – $2.2B	$2.0B (+27%)	after a round	–	unknown	A	0%
1 Oct 2020	$1.6B	$1.3B – $2.2B	$2.0B (+24%)	after a round	–	unknown	A	0%
1 Nov 2020	$1.6B	$1.3B – $2.2B	$2.0B (+21%)	after a round	–	unknown	A	0%
1 Dec 2020	$1.6B	$1.3B – $2.2B	$2.0B (+19%)	after a round	–	unknown	A	0%
1 Jan 2021	$1.7B	$1.3B – $2.2B	$2.0B (+16%)	after a round	8	unknown	A	0%
1 Feb 2021	$1.7B	$1.3B – $2.2B	$2.0B (+13%)	after a round	8	unknown	A	0%
1 Mar 2021	$1.8B	$1.3B – $2.2B	$2.0B (+11%)	after a round	8	unknown	A	0%
24 Mar 2021	$5.0B	$4.3B – $7.5B	$6.5B (+30%)	after a round	8	unknown	A	0%
1 Apr 2021	$5.0B	$4.3B – $7.5B	$6.5B (+29%)	after a round	8	unknown	A	0%
1 May 2021	$5.7B	$4.3B – $18.5B	$16.1B (+184%)	after a round	490	growing	C	0%
1 Jun 2021	$6.3B	$4.3B – $18.5B	$16.1B (+157%)	after a round	490	growing	C	0%
1 Jul 2021	$6.9B	$4.3B – $18.5B	$16.1B (+133%)	after a round	490	growing	C	0%
1 Aug 2021	$7.6B	$4.3B – $18.5B	$16.1B (+111%)	after a round	490	growing	C	0%
1 Sep 2021	$8.4B	$4.3B – $18.5B	$16.1B (+92%)	after a round	490	growing	C	0%
1 Oct 2021	$9.2B	$4.3B – $18.5B	$16.1B (+74%)	after a round	490	growing	C	0%
1 Nov 2021	$10.2B	$4.3B – $18.5B	$16.1B (+58%)	after a round	490	growing	C	0%
1 Dec 2021	$11.2B	$4.3B – $18.5B	$16.1B (+43%)	after a round	490	growing	C	0%
1 Jan 2022	$12.4B	$4.3B – $18.5B	$16.1B (+30%)	after a round	490	growing	C	0%
1 Feb 2022	$13.7B	$4.3B – $18.5B	$16.1B (+17%)	after a round	490	growing	C	0%
16 Feb 2022	$7.0B	$6.1B – $8.9B	$7.7B (+10%)	after a round	490	growing	A	0%
1 Mar 2022	$7.0B	$6.1B – $8.9B	$7.7B (+10%)	after a round	490	growing	A	0%
1 Apr 2022	$7.1B	$6.1B – $8.9B	$7.7B (+9%)	after a round	490	growing	A	0%
1 May 2022	$7.1B	$6.1B – $8.9B	$7.7B (+8%)	after a round	490	growing	A	0%
1 Jun 2022	$7.2B	$6.1B – $8.9B	$7.7B (+7%)	after a round	490	growing	A	0%
1 Jul 2022	$7.3B	$6.1B – $8.9B	$7.7B (+6%)	after a round	490	growing	A	0%
1 Aug 2022	$7.3B	$6.1B – $8.9B	$7.7B (+5%)	after a round	490	growing	A	0%
1 Sep 2022	$7.4B	$6.1B – $8.9B	$7.7B (+4%)	after a round	490	growing	A	0%
1 Oct 2022	$7.4B	$6.1B – $8.9B	$7.7B (+4%)	after a round	490	growing	A	0%
1 Nov 2022	$7.5B	$6.1B – $8.9B	$7.7B (+3%)	after a round	490	unknown	A	0%
1 Dec 2022	$7.5B	$6.1B – $8.9B	$7.7B (+2%)	after a round	490	unknown	A	0%
1 Jan 2023	$7.6B	$6.1B – $8.9B	$7.7B (+1%)	after a round	490	unknown	A	0%
1 Feb 2023	$7.7B	$6.1B – $8.9B	$7.7B (0%)	after a round	490	unknown	A	0%
1 Mar 2023	$7.7B	$5.9B – $8.9B	$7.7B (0%)	after a round	490	unknown	A	0%
1 Apr 2023	$7.7B	$5.7B – $8.9B	$7.7B (0%)	after a round	770	unknown	A	0%
1 May 2023	$7.7B	$5.4B – $8.9B	$7.7B (0%)	after a round	770	unknown	A	0%
1 Jun 2023	$7.7B	$5.1B – $8.9B	$7.7B (0%)	after a round	770	unknown	A	0%
1 Jul 2023	$7.7B	$4.9B – $8.9B	$7.7B (0%)	after a round	770	unknown	A	0%
1 Aug 2023	$7.7B	$4.6B – $8.9B	$7.7B (0%)	after a round	770	unknown	B	0%
1 Sep 2023	$7.7B	$4.4B – $8.9B	$7.7B (0%)	after a round	770	unknown	B	0%
1 Oct 2023	$7.7B	$4.2B – $8.9B	$7.7B (0%)	after a round	820	flat	B	0%
1 Nov 2023	$7.7B	$4.0B – $8.9B	$7.7B (0%)	after a round	820	flat	B	0%
1 Dec 2023	$7.7B	$3.8B – $8.9B	$7.7B (0%)	after a round	820	flat	B	0%
1 Jan 2024	$7.7B	$3.6B – $8.9B	$7.7B (0%)	after a round	820	flat	B	0%
1 Feb 2024	$7.7B	$3.4B – $8.9B	$7.7B (0%)	after a round	820	flat	B	0%
1 Mar 2024	$7.7B	$4.0B – $8.9B	$7.7B (0%)	after a round	860	up	B	0%
1 Apr 2024	$7.7B	$3.9B – $8.9B	$7.6B (-1%)	after a round	860	up	B	0%
1 May 2024	$7.7B	$3.7B – $8.9B	$7.6B (-1%)	after a round	860	up	B	0%
1 Jun 2024	$7.7B	$3.6B – $8.9B	$7.6B (-2%)	after a round	860	up	B	0%
1 Jul 2024	$7.7B	$3.5B – $8.9B	$7.5B (-2%)	after a round	860	up	B	0%
1 Aug 2024	$7.7B	$3.4B – $8.9B	$7.6B (-1%)	after a round	970	up	B	0%
1 Sep 2024	$7.7B	$3.2B – $8.9B	$7.6B (-1%)	after a round	970	up	B	0%
1 Oct 2024	$7.7B	$3.1B – $8.9B	$7.6B (-2%)	after a round	970	up	B	0%
1 Nov 2024	$7.7B	$3.0B – $8.9B	$7.5B (-2%)	after a round	990	up	B	0%
1 Dec 2024	$7.7B	$2.9B – $8.9B	$7.5B (-2%)	after a round	990	up	B	0%
1 Jan 2025	$7.7B	$2.8B – $8.9B	$7.5B (-3%)	after a round	990	up	B	0%
1 Feb 2025	$7.7B	$2.7B – $8.9B	$7.5B (-3%)	after a round	990	up	B	0%
1 Mar 2025	$7.7B	$2.2B – $8.8B	$7.4B (-3%)	after a round	990	up	C	0%
1 Apr 2025	$7.7B	$2.1B – $8.8B	$7.4B (-3%)	after a round	990	up	C	0%
1 May 2025	$7.6B	$2.0B – $8.8B	$7.2B (-5%)	after a round	990	up	C	0%
1 Jun 2025	$7.6B	$2.0B – $8.7B	$7.2B (-5%)	after a round	990	up	C	0%
1 Jul 2025	$7.7B	$1.9B – $8.8B	$7.7B (0%)	after a round	1,160	up	C	0%
1 Aug 2025	$7.7B	$3.7B – $8.9B	$7.7B (0%)	after a round	1,199	growing	B	0%
1 Sep 2025	$7.7B	$3.7B – $8.9B	$7.7B (0%)	after a round	1,199	growing	B	0%
1 Oct 2025	$7.6B	$1.7B – $8.7B	$7.4B (-3%)	after a round	1,199	up	C	0%
1 Nov 2025	$7.7B	$1.6B – $8.8B	$7.7B (0%)	after a round	1,300	up	C	0%
1 Dec 2025	$7.7B	$1.5B – $8.8B	$7.7B (0%)	after a round	1,300	up	C	0%
1 Jan 2026	$7.7B	$1.5B – $8.8B	$7.7B (0%)	after a round	1,300	up	C	0%
1 Feb 2026	$7.7B	$3.3B – $8.9B	$7.7B (0%)	after a round	1,415	growing	B	0%
1 Mar 2026	$7.7B	$3.5B – $8.9B	$7.7B (0%)	after a round	1,415	growing	B	0%
1 Apr 2026	$7.7B	$3.5B – $8.9B	$7.7B (0%)	after a round	1,415	growing	B	0%
1 May 2026	$7.7B	$3.4B – $8.9B	$7.7B (0%)	after a round	1,415	growing	B	0%
1 Jun 2026	$7.5B	$1.3B – $8.6B	$7.4B (-2%)	after a round	1,470	up	C	0%
1 Jul 2026	$7.5B	$1.3B – $8.6B	$7.4B (-2%)	after a round	1,470	up	C	0%
1 Aug 2026	$7.5B	$1.2B – $8.6B	$7.4B (-2%)	after a round	1,470	up	C	0%
1 Sep 2026	$7.5B	$1.2B – $8.6B	$7.4B (-2%)	after a round	1,477	up	C	0%
1 Oct 2026	$7.5B	$1.1B – $8.6B	$7.3B (-2%)	after a round	1,481	up	D	0%
24 Oct 2026	$5.7B	$844M – $8.6B	$5.6B (-2%)	after a round	1,481	up	D	0%

Key facts about Ro

Founded: 2017
Headquarters: New York, United States
Employees: about 1,480 +24% in a year
Total raised: $1.03B
Funding rounds: 6
Last round: Growth Equity Feb 2022

Ro was founded in 2017 by Rob Schutz, Saman Rahmanian and Zachariah Reitano.

Ro funding history

Ro has 6 funding rounds on record, from Aug 2017 to Feb 2022, $1.03B in total. The latest disclosed valuation is $7.00B post-money (Growth Equity, Feb 2022).

Growth Equity 15 Feb 2022
Led by ShawSpring Partners; with General Catalyst, FirstMark, TQ Ventures, SignalFire, BoxGroup, The Chernin Group, Initialized, Altimeter, The Baupost Group, Seven Seven Six.
Sources: prnewswire.com, techcrunch.com, gcimagazine.com and 3 more
$150M
$7.00B post-money
Series D 23 Mar 2021
Led by General Catalyst, FirstMark, TQ Ventures; with SignalFire, Torch Capital, BoxGroup, Altimeter, The Baupost Group, Dragoneer Investment Group, ShawSpring Partners, Radcliff, Seven Seven Six.
Sources: prnewswire.com, fiercehealthcare.com, medcitynews.com and 2 more
$500M
$5.00B post-money
Series C 27 Jul 2020
Led by General Catalyst; with FirstMark, SignalFire, TQ Ventures, Initialized, 3L Growth Equity, BoxGroup, The Chernin Group.
Sources: ro.co, alleywatch.com, cnbc.com
$200M
$1.50B post-money
Series B 16 Apr 2019
Led by FirstMark; with 3L Growth Equity, Sand Hill Angels, J-Ventures, Gaingels, Torch Capital, TQ Ventures.
Sources: techcrunch.com, cbsnews.com, mobihealthnews.com and 1 more
$85M
$500M post-money
Series A 19 Sep 2018
Led by FirstMark; with SignalFire, Initialized, General Catalyst, Slow Ventures, Sinai Ventures, Torch Capital, BoxGroup, Tusk Venture Partners.
Sources: finsmes.com, techcrunch.com, techcrunch.com
$88M
Seed 3 Aug 2017
With 3L Growth Equity, Altimeter Capital Management LLC, BoxGroup, Dragoneer Investment Group, FirstMark, General Catalyst, Initialized, Rosecliff Ventures, Seven Seven Six, ShawSpring Partners, SignalFire, Sinai Ventures, Slow Ventures, The Baupost Group, The Chernin Group, The Radcliff Companies, Torch Capital, Torch Venture Capital, TQ Ventures, Tusk Venture Partners.
Sources: public.com
$3.0M

Ro investors

25 investors have backed Ro; FirstMark, General Catalyst and TQ Ventures and 1 more led at least one round.

FirstMark lead, 8 rounds
General Catalyst lead, 5 rounds
BoxGroup 5 rounds
Seven Seven Six 3 rounds
The Chernin Group 3 rounds
Altimeter 2 rounds
Dragoneer Investment Group 2 rounds
Sinai Ventures 2 rounds
Altimeter Capital Management LLC
Gaingels
Radcliff
The Radcliff Companies
Torch Venture Capital

What Ro does

Ro works in health care services, with 15 recorded offerings and customers in healthcare and health technology.

Ro is an American healthcare company that operates a vertically integrated platform providing telehealth, laboratory testing, and pharmacy services. The company offers digital healthcare solutions, including online consultations, fertility hormone testing, and at-home diagnostic testing, as well as pharmacy services for medication delivery. Ro also provides in-home care through a proprietary API and supports other healthcare providers with its platform. Its services are available to individuals seeking fertility testing, weight loss support, and skincare solutions.

Description from Veridion's company data.

Products and services

Telehealth Services
Specialized Medical Treatment Delivery
Fertility Testing Services
Fertility Nurse Consultation Services
Sexual Health Services
Weight Loss Support Services
Weight Loss Supplement Retail
Hair Loss Services
Hair Loss Treatment Delivery
Skincare Solutions Delivery
At-Home Diagnostic Testing Services
Pharmacy Services
Online Health Community Services
In-Home Care API Development
Healthcare Platform Solutions Development

Markets

Healthcare
Health Technology

Business model

Business-to-Consumer
Service Provider
Healthcare

Industry codes (NAICS)

621999 All Other Miscellaneous Ambulatory Health Care Services 40% match
456110 Pharmacies and Drug Retailers 25% match
621511 Medical Laboratories 20% match
456199 All Other Health and Personal Care Retailers 15% match

Questions about Ro

What is Ro worth?

Valuation $5.7B (range $844M to $8.6B), as of 24 Oct 2026. The last disclosed valuation was $7.00B (Growth Equity, Feb 2022).

Has Ro raised money?

Ro has 6 funding rounds on record, from Aug 2017 to Feb 2022, $1.03B in total. The latest disclosed valuation is $7.00B post-money (Growth Equity, Feb 2022).

Who has invested in Ro?

FirstMark, General Catalyst, TQ Ventures, ShawSpring Partners, BoxGroup and Initialized, and 19 more. Lead investors include FirstMark, General Catalyst, TQ Ventures and ShawSpring Partners.

How many people work at Ro?

About 1,480, up 24% over the last year. Headcount grew from 8 in Jan 2021 to 1,481 in Sep 2026.

What does Ro do?

Ro works in health care services, with 15 recorded offerings and customers in healthcare and health technology. Its main offerings are telehealth services, specialized medical treatment delivery and fertility testing services.

When was Ro founded, and where is it based?

Ro was founded in 2017 and is based in New York, United States. It has about 1,480 employees, up 24% over the last year.

How we value companies Report an issue

Ro valuation, funding and investors

Ro valuation today

Key facts about Ro

Ro funding history

Growth Equity 15 Feb 2022

Series D 23 Mar 2021

Series C 27 Jul 2020

Series B 16 Apr 2019

Series A 19 Sep 2018

Seed 3 Aug 2017